Filed: 8/14/2026ACC: 0001615982-26-000015
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $3.30B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$3.30B
Total AUM (reported)
130.54M
Total Shares
Allocation by class
COM$2.67B80.9%
COM NEW$537.30M16.3%
CLASS A ORD SHS$37.97M1.2%
SPONSORED ADS$36.95M1.1%
COM SHS$13.20M0.4%
ORD SHS CL A$3.21M0.1%
Portfolio Concentration
Top 3$1.85B56.1%
4–10$801.35M24.3%
11–25$556.51M16.9%
Rest$90.29M2.7%
Top 3 weight
56.1%
Top 10 weight
80.4%
Voting Authority Distribution
Total shares with voting rights: 130.54M
Sole
Full voting authority
130.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$1.13B
34.18%
Sole
8.49M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$394.81M
11.97%
Sole
4.15M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares17.89M
TypeSH
Market value$327.78M
9.94%
Sole
17.89M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.99M
TypeSH
Market value$265.05M
8.04%
Sole
2.99M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.18M
TypeSH
Market value$115.03M
3.49%
Sole
1.18M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares10.35M
TypeSH
Market value$101.61M
3.08%
Sole
10.35M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares3.60M
TypeSH
Market value$93.73M
2.84%
Sole
3.60M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares14.75M
TypeSH
Market value$90.84M
2.75%
Sole
14.75M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares3.22M
TypeSH
Market value$71.56M
2.17%
Sole
3.22M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.64M
TypeSH
Market value$63.55M
1.93%
Sole
1.64M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.26M
TypeSH
Market value$59.85M
1.81%
Sole
3.26M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares3.04M
TypeSH
Market value$56.00M
1.70%
Sole
3.04M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$48.28M
1.46%
Sole
2.17M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares1.60M
TypeSH
Market value$47.80M
1.45%
Sole
1.60M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares6.84M
TypeSH
Market value$47.36M
1.44%
Sole
6.84M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.32M
TypeSH
Market value$46.78M
1.42%
Sole
4.32M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares2.13M
TypeSH
Market value$38.40M
1.16%
Sole
2.13M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares6.43M
TypeSH
Market value$37.97M
1.15%
Sole
6.43M
Shared
0.00
None
0.00
ADLAI NORTYE LTD
SOLEShares3.21M
TypeSH
Market value$36.95M
1.12%
Sole
3.21M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares526.33K
TypeSH
Market value$26.71M
0.81%
Sole
526.33K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares3.85M
TypeSH
Market value$25.46M
0.77%
Sole
3.85M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$25.13M
0.76%
Sole
1.38M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares8.70M
TypeSH
Market value$21.30M
0.65%
Sole
8.70M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares2.04M
TypeSH
Market value$19.82M
0.60%
Sole
2.04M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares4.98M
TypeSH
Market value$18.68M
0.57%
Sole
4.98M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $1.13B 34.18% | 8.49M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $394.81M 11.97% | 4.15M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 17.89M | SH | $327.78M 9.94% | 17.89M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.99M | SH | $265.05M 8.04% | 2.99M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.18M | SH | $115.03M 3.49% | 1.18M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 10.35M | SH | $101.61M 3.08% | 10.35M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 3.60M | SH | $93.73M 2.84% | 3.60M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 14.75M | SH | $90.84M 2.75% | 14.75M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 3.22M | SH | $71.56M 2.17% | 3.22M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.64M | SH | $63.55M 1.93% | 1.64M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.26M | SH | $59.85M 1.81% | 3.26M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 3.04M | SH | $56.00M 1.70% | 3.04M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $48.28M 1.46% | 2.17M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 1.60M | SH | $47.80M 1.45% | 1.60M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 6.84M | SH | $47.36M 1.44% | 6.84M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.32M | SH | $46.78M 1.42% | 4.32M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 2.13M | SH | $38.40M 1.16% | 2.13M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 6.43M | SH | $37.97M 1.15% | 6.43M | 0.00 | 0.00 |
ADLAI NORTYE LTDSOLE | SPONSORED ADS | 3.21M | SH | $36.95M 1.12% | 3.21M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 526.33K | SH | $26.71M 0.81% | 526.33K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 3.85M | SH | $25.46M 0.77% | 3.85M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $25.13M 0.76% | 1.38M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 8.70M | SH | $21.30M 0.65% | 8.70M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 2.04M | SH | $19.82M 0.60% | 2.04M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 4.98M | SH | $18.68M 0.57% | 4.98M | 0.00 | 0.00 |
Page 1 of 2